Literature DB >> 19321257

Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells.

Haiyun Deng1, T S Ravikumar, Weng-Lang Yang.   

Abstract

Bone morphogenetic proteins (BMP), a member of the TGF-beta superfamily, have broad activities in regulating various kinds of cellular behaviors. Previously, we have demonstrated that BMP-4 is up-regulated in human colonic adenocarcinoma and promotes the invasive phenotypes of human colorectal cancer HCT116 cells. Smad4 is a central mediator in BMP signaling pathway and it is frequently mutated in metastatic colorectal cancers. To address whether Smad4 was required for enhancing metastatic potentials by BMP-4 in colorectal cancer, we generated BMP-4 overexpressing clones from Smad4-deficient SW480 cells. The growth rate of BMP-4 overexpressing cells was slightly higher than that of empty-vector controls. Overexpression of BMP-4 resulted in an increased expression of vimentin, a marker of epithelial-mesenchymal transition, and caused the changes of cell morphology, spreading and formation of focal adhesions. BMP-4 overexpressing cells increased cell adhesion on fibronectin and collagen, and augmented cell migration and invasion potentials in comparison to empty-vector controls. The induction of cell migration by BMP-4 overexpression was inhibited by BMP-4 siRNA. To further identify the target genes of the elevated BMP-4 signaling in SW480 cells, an oligonucleotide microarray was performed. Among 46,000 genes, 91 genes (65 up-regulated and 26 down-regulated) with 2-fold difference have been identified between BMP-4 overexpressing and empty-vector cells. This study demonstrates that Smad4 is dispensable for enhanced invasiveness of human colorectal cancer cells due to BMP-4 overexpression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19321257     DOI: 10.1016/j.canlet.2009.02.046

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  20 in total

1.  Inhibition of bone morphogenetic protein signaling reduces viability, growth and migratory potential of non-small cell lung carcinoma cells.

Authors:  Jelena Mihajlović; Laura A M Diehl; Andreas Hochhaus; Joachim H Clement
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-17       Impact factor: 4.553

Review 2.  The Yin and Yang of bone morphogenetic proteins in cancer.

Authors:  Ashok Singh; Rebecca J Morris
Journal:  Cytokine Growth Factor Rev       Date:  2010-08-04       Impact factor: 7.638

3.  Shared ACVR1 mutations in FOP and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases.

Authors:  Harry J Han; Payal Jain; Adam C Resnick
Journal:  Bone       Date:  2017-08-02       Impact factor: 4.398

4.  Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth.

Authors:  Catherine E Gatza; Alisha Holtzhausen; Kellye C Kirkbride; Allyson Morton; Michael L Gatza; Michael B Datto; Gerard C Blobe
Journal:  Neoplasia       Date:  2011-08       Impact factor: 5.715

5.  Bone morphogenetic protein-4 polymorphism and colorectal cancer risk: a meta analysis.

Authors:  Jin Li; Chuang Sun; Yuerong Yuan; Li Liu; Guanglian Xiong; Jing Wu
Journal:  Mol Biol Rep       Date:  2011-12-15       Impact factor: 2.316

6.  Single nucleotide polymorphisms in the Wnt and BMP pathways and colorectal cancer risk in a Spanish cohort.

Authors:  Ceres Fernández-Rozadilla; Luisa de Castro; Juan Clofent; Alejandro Brea-Fernández; Xavier Bessa; Anna Abulí; Montserrat Andreu; Rodrigo Jover; Rosa Xicola; Xavier Llor; Antoni Castells; Sergi Castellví-Bel; Angel Carracedo; Clara Ruiz-Ponte
Journal:  PLoS One       Date:  2010-09-09       Impact factor: 3.240

7.  Bone morphogenetic protein 4 (BMP4) signaling in retinoblastoma cells.

Authors:  Maike Haubold; Andreas Weise; Harald Stephan; Nicole Dünker
Journal:  Int J Biol Sci       Date:  2010-11-24       Impact factor: 6.580

8.  Novel bone morphogenetic protein signaling through Smad2 and Smad3 to regulate cancer progression and development.

Authors:  Alisha Holtzhausen; Christelle Golzio; Tam How; Yong-Hun Lee; William P Schiemann; Nicholas Katsanis; Gerard C Blobe
Journal:  FASEB J       Date:  2013-12-05       Impact factor: 5.191

9.  Role of two single nucleotide polymorphisms in secreted frizzled related protein 1 and bladder cancer risk.

Authors:  Anja Rogler; Sabine Hoja; Eileen Socher; Elke Nolte; Sven Wach; Wolf Wieland; Ferdinand Hofstädter; Peter J Goebell; Bernd Wullich; Arndt Hartmann; Robert Stoehr
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

10.  Cathepsin H indirectly regulates morphogenetic protein-4 (BMP-4) in various human cell lines.

Authors:  Matija Rojnik; Zala Jevnikar; Bojana Mirkovic; Damjan Janes; Nace Zidar; Danijel Kikelj; Janko Kos
Journal:  Radiol Oncol       Date:  2011-10-08       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.